How to run a compliant peptide affiliate program

Paid social is largely closed to this category, which pushes almost every peptide brand toward creators and affiliates. That is the right instinct. It is also the fastest way to hand a regulator a stack of claims you did not write and cannot take back.

The good news is that the rules here are unusually clear, they have been in force since 2023, and building against them properly is a one-time exercise.

The rules that apply

The FTC's revised Endorsement and Testimonial Guides took effect on 26 July 2023. Four changes matter most:

• Disclosure must be clear and conspicuous, in the same medium as the endorsement. Platform-native tools alone are not sufficient. A buried tag or a disclosure below a “more” fold does not satisfy it.
• Influencers can be sued directly. Liability is no longer only the brand's problem, which changes how you should talk to partners about it.
• Atypical results must be substantiated or disclosed. The old “results not typical” disclaimer no longer defuses the issue.
• Review integrity is enforceable. Procuring, suppressing, or distorting consumer reviews is a violation in itself.

Civil penalties can exceed $50,000 per violation per day. In November 2023 the FTC sent warning letters to a dozen online health influencers over inadequate disclosures, so the enforcement posture is not theoretical.

The compounding problem in this category

For most industries, endorsement compliance is about disclosure. Here, there are two layers, and the second one is the dangerous one.

An affiliate discloses properly and is still a serious problem for you if the content makes a human-use or benefit claim. Your compliance posture is judged on the totality of how your product is marketed, and content published on your behalf is part of that. A creator saying what a compound did for their recovery is a human-use claim attached to your brand, disclosed or not.

So you are enforcing two things at once: disclose the relationship and do not make the claim. Most affiliate programmes in this category do neither.

What goes in the agreement

Put these in writing before anyone gets a link. An agreement is also the artifact that shows you took reasonable steps, which matters if something goes wrong.

• Mandatory disclosure, specified exactly. Say what the disclosure must say, where it must appear, and that it must be visible without expanding, clicking, or scrolling past.
• Prohibited claims, listed explicitly. No disease claims. No treatment, cure, prevention, or mitigation language. No dosing or protocol guidance. No before-and-after body imagery. No personal-results narratives. No naming approved drug brands.
• No human-use framing of any kind, including implied use through imagery, captions, or comments.
• Approved-language provision. Give them copy that works rather than only telling them what is banned.
• Pre-approval for the first pieces, and spot review afterwards.
• Right to require takedown, with a defined response window.
• Termination for breach, and forfeiture of commissions on non-compliant content.
• No incentivised or scripted reviews, and no suppression of negative ones.

The operational part everyone skips

An agreement nobody monitors is a document, not a control. What actually makes the difference:

• Give partners a copy pack. Most non-compliant affiliate content is not defiance, it is a creator filling a vacuum. If you supply approved language, hooks, and product facts, most of them will use it because it is easier.
• Review on a schedule rather than when something goes wrong. Put a recurring slot in the calendar to look at live partner content.
• Keep the records. Signed agreements, the copy pack you issued, dated review logs, takedown requests and responses. This is the file that demonstrates a programme rather than an arrangement.
• Terminate when you have to. A high-performing affiliate making claims is a liability that scales with their performance.

Why this is worth the effort

It would be easy to read all of this as a reason not to run affiliates. I would argue the opposite, for two reasons.

First, the alternative channels are worse. Paid social in this category generally requires either claims you cannot make or deception of the ad review system, and the platform risk lands on the seller.

Second, and more interesting: the compliance requirement is a competitive moat if you treat it as one. Running a properly documented affiliate programme is genuinely more work than handing out discount codes, which is exactly why most competitors will not do it. The brands that build it get a durable channel that does not disappear on a Tuesday, and partners who prefer working with a brand that will not get them personally sued.

The rules are public, the deadline for adapting to them passed in 2023, and most of the category still has not.

This guide is general information, not legal advice. It summarises publicly available FTC guidance and enforcement activity as of writing; guides are not binding statute and agency positions evolve. Have qualified counsel review your affiliate agreement and programme before you launch it.